ConferenceAffluent Medical Announces Participation in Upcoming Scientific Events 08.10.2024 / 17:45 CET/CESTThe issuer is solely responsible for the content of this announcement.PRESS RELEASE Affluent ...
Following positive feedback from the FDA in September 2024, Affluent Medical’s objective is to submit a De Novo application with current clinical data at the end of 2025/early 2026, followed by ...